Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Ex-Haleon VP Bas Vorsteveld joins Kenvue

Kenvue appoints Bas Vorsteveld as area managing director for Northern Europe
Bas Vorsteveld will now oversee the Kenvue’s business in Northern Europe

Bas Vorsteveld announced his departure from Haleon in October 2024, after “a journey of nearly 19 amazing years”

Bas Vorsteveld, former Haleon’s vice-president and general manager for Great Britain and Ireland (GBI), has been appointed as Kenvue's new area managing director for Northern Europe.

In his new role, he will oversee the company’s operations across the UK, Ireland, Norway, Sweden, Denmark, and Finland, managing a portfolio of iconic brands, including Nicorette, Aveeno, Johnson’s Baby, Listerine, Neutrogena, Calpol, OGX, and Imodium.


Vorsteveld has over 30 years of experience in consumer goods and healthcare.

At Haleon, he played a pivotal role in driving its GBI business following its separation from GSK, delivering significant growth and earning notable recognition, including Best Company at the UK Pharmacy Awards 2024.

He announced his departure from Haleon in October 2024, after “a journey of nearly 19 amazing years.”

Until recently, Vorsteveld was president of the board of the PAGB, spearheading the organisation’s five-year strategy focused on advancing self-care to help alleviate healthcare pressures.

He has held several roles across Europe with GSK Consumer Healthcare including VP & Head of Commercial Excellence EMEA, VP & General Manager France and French speaking Africa & Maghreb, and GM Benelux. Prior to that, he held GM roles at Novartis. He started his career at Campina.

Expressing his enthusiasm for the new role, Vorsteveld said: “Kenvue’s iconic brands speak for themselves, and I am excited by the truly holistic approach to self-care we can offer through the entire range of different categories we thrive in.

“I’m thrilled to join the Northern Europe team, and I look forward to getting out across the region to spend time with our customers and stakeholders across the industry as well as our dedicated team.”

Welcoming Bas to the leadership team, Carlton Lawson, group president, Europe, Middle East, Africa and Latin America at Kenvue, said: “With almost three decades of experience in consumer goods and healthcare, Bas brings a proven track record of delivering industry leading growth, building high performing teams and deep industry knowledge that will be invaluable as we work to further boost Kenvue’s regional performance and growth.

“I’m confident that his experience advocating for the role our industry can and should play in promoting the value of self-care will help us deliver on our clear purpose to put the power of everyday care into the hands of more consumers.”

More For You

Call to improve inclusivity in clinical research

Ethnic minority adults continue to be underrepresented in clinical trials.

iStock

Call to improve inclusivity in clinical research

A NEW report has called for the participation of a wide range of diverse communities in clinical research to make sure that the medicines meet the needs of the UK's increasingly diverse population.

The report ‘Achieving inclusivity in clinical research’, prepared by the Association of the British Pharmaceutical Industry (ABPI) and the Association of Medical Research Charities (AMRC), highlights the long-standing challenges in ensuring diversity in clinical trials.

Keep ReadingShow less
Pharmacy students Learning Support Fund

Pharmacy students will be included in the Travel and Dual Accommodation Expenses section of the NHS Learning Support Fund.

iStock

Pharmacy students to have access to Learning Support Fund

FOR the first time in England, pharmacy students will be eligible to reimburse travel and accommodation costs while attending placements.

The Department of Health and Social Care confirmed that pharmacy students would finally be included in the Travel and Dual Accommodation Expenses (TDAE) section of the NHS Learning Support Fund (LSF).

Keep ReadingShow less
NHS for robotic surgery

Patients undergoing robotic surgery are able to recover quicker and be discharged sooner.

Pic credit: iStock

NHS pushes for robotic surgery to reduce waiting time, improve outcomes

The NHS is planning to step up robotic surgery over the next decade to reduce waiting time, help in the speed of recovery of patients, and shorter hospital stay.

As per the NHS projections, the number is expected to zoom from 70,000 in 2023/24 to half a million by 2035.

Keep ReadingShow less
Scotland's digital patient care record

The amendment ensures that every person who receives health care or a social service in Scotland will have a digital care record

Pic credit: iStock

Scotland's move to create digital patient care record hailed

The Royal Pharmaceutical Society (RPS) in Scotland has welcomed the decision of the Scottish Parliament to create an integrated digital patient care record.

The move came during a debate on the Care Reform (Scotland) Bill on Tuesday (10), when Jackie Baillie tabled an amendment to ensure that every person who receives health care or a social service in Scotland has a digital care record.

Keep ReadingShow less
A woman using a period tracker app

Cambridge University academics have flagged concerns over the safety of period tracker apps

Pic credit: iStock

Users of period tracking apps face privacy, safety risk, say experts

The report said the apps provide a "gold mine" of data for consumer profiling and warn that in the wrong hands it could pose a safety risk

CAMBRIDGE UNIVERSITY academics have flagged concerns over the safety of period tracker apps and warned that the women using them could face privacy and safety risks.

Keep ReadingShow less